Pasithea Therapeutics Stock Forecast - Value At Risk

KTTAW Stock  USD 0.02  0  11.11%   
Pasithea Stock Forecast is based on your current time horizon.
  
Payables Turnover is likely to climb to 0.27 in 2024. Fixed Asset Turnover is likely to climb to 0.63 in 2024. Common Stock Shares Outstanding is likely to drop to about 1.2 M in 2024.
Pasithea Therapeutics Corp has current Value At Risk of 0.
Check Pasithea Therapeutics VolatilityBacktest Pasithea TherapeuticsInformation Ratio  

Pasithea Therapeutics Trading Date Momentum

On November 21 2024 Pasithea Therapeutics Corp was traded for  0.02  at the closing time. The highest daily price throughout the period was 0.03  and the lowest price was  0.02 . The daily volume was 22.7 K. The net trading volume on 11/21/2024 did not cause price change. The trading delta at closing time to current closing price is 0.50% .
Compare Pasithea Therapeutics to competition

Pasithea Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pasithea Therapeutics stock to make a market-neutral strategy. Peer analysis of Pasithea Therapeutics could also be used in its relative valuation, which is a method of valuing Pasithea Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Pasithea Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Pasithea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pasithea Therapeutics shares will generate the highest return on investment. By undertsting and applying Pasithea Therapeutics stock market strength indicators, traders can identify Pasithea Therapeutics Corp entry and exit signals to maximize returns.

Pasithea Therapeutics Risk Indicators

The analysis of Pasithea Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pasithea Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pasithea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.